隆乳术后乳房假体相关间变性大细胞淋巴瘤1例  

Breast implant associated-anaplastic large cell lymphoma after breast augmentation surgery:a case report

作　　者：才杰[1] 周洋[1] 李振玲[2] 宋爱平[3] 钟定荣 Cai Jie;Zhou Yang;Li Zhenling;Song Aiping;Zhong Dingrong(Department of Plastic Surgery,China-Japan Friendship Hospital,Beijing 100029,China;Department of Hematology,China-Japan Friendship Hospital,Beijing 100029,China;Department of Pathology,China-Japan Friendship Hospital,Beijing 100029,China)

机构地区：[1]中日友好医院整形外科,北京100029 [2]中日友好医院血液科,北京100029 [3]中日友好医院病理科,北京100029

出　　处：《中华整形外科杂志》2023年第12期1349-1352,共4页Chinese Journal of Plastic Surgery

摘　　要：乳房假体相关间变性大细胞淋巴瘤非常罕见。该例女性患者,39岁,行假体隆乳术后10年余,近1年多左乳持续肿胀疼痛来诊。经手术取出原假体(国产水滴型硅胶假体,260 ml),并完整切除左侧乳房假体包膜。术后病理确诊为乳房假体相关间变性大细胞淋巴瘤。患者术后恢复良好。该病例在中国内地为首次报道,提示医生应该对此类疾病高度重视,及时准确予以诊断及治疗。Breast implant associated-anaplastic large cell lymphoma(BIA-ALCL)is very rare.This 39-year-old female patient,more than 10 years after breast augmentation surgery,had suffered left breast swelling and pain for more than 1 year.The original implant(domestic anatomic shape silicone implant,260 ml)was surgically removed and the capsule of the left breast implant was completely removed.Postoperative pathology confirmed the diagnosis of BIA-ALCL.The patient recovered well after the surgery.This case is the first one reported in China mainland,which suggest that doctors should attach great importance to the diseases,and diagnose and treat it timely and accurately.

关 键 词：乳房植入物 淋巴瘤 大细胞 间变性 CD30 

分 类 号：R655.8[医药卫生—外科学]